Abstract
Levetiracetam is an antiepileptic drug (AED) with a favourable tolerability profile with little or no effect on liver function. We describe an epileptic patient who developed a significant increase in gamma glutamyltransferase (gammaGT) while on levetiracetam monotherapy.
MeSH terms
-
Anticonvulsants / adverse effects
-
Drug Monitoring
-
Epilepsies, Partial / blood
-
Epilepsies, Partial / drug therapy*
-
Female
-
Humans
-
Levetiracetam
-
Liver / drug effects*
-
Middle Aged
-
Piracetam / adverse effects
-
Piracetam / analogs & derivatives*
-
Treatment Outcome
-
gamma-Glutamyltransferase / blood*
Substances
-
Anticonvulsants
-
Levetiracetam
-
gamma-Glutamyltransferase
-
Piracetam